| abstract |
As a method of preparing a compound of formula (I), the method includes the following steps: (a) an intermediate of formula (7) by treating a compound of formula (5) with a compound of formula (6) Producing a compound; (b) treating a compound of formula (7) as defined above with a compound of formula (8); And (c) recovering the compound of formula (I) as defined above. The compound of formula (I) is a promising modulator of p300/CBP activity with potential utility in cancer treatment, including prostate cancer, hematologic cancer, bladder cancer and lung cancer. |